China Sky One Medical (AMEX: CSY) reported that it has 11 new drugs in clinical trials,
seven of them administered by injection. The clinical trials are expected to be
underway for six months. Assuming the trials are successful, China Sky One
projects it will submit the drugs for SFDA approval in early 2009.
China
Sky One has traditionally emphasized externally administered products (patches
and ointments), but it has been building up its product portfolio by acquiring
other companies.
So far in 2008, China Sky One has bought Heilongjiang
Tianlong Pharmaceutical (price: $8.3 million) and Peng Lai Jin Chuang Company
(price: $7.1 million). Heilongjiang Tianlong was responsible for the propyl
gallate injection, whose approval China Sky One announced earlier this week. It
has also previously announced that Heilongjiang Tianlong completed the R&D
work on eight other injected products.
The following is a list of the
products that China Sky One has in clinical trials:
• Povidone Iodine
Suppository: for treatment of moniliasis colpitis, bacterial colpitis, and
hemorrhoids;
• Gabexate Mesylate Injection: for treatment of acute
pancreatitis and acute hemorrhagic necrosis of the pancreas;
• Ciclopirox
Ointment: for treatment of superficial fungal infection, such as Tinea manuum
and Tinea pedis;
• Ciclopirox Olamine Vaginal Suppositories: for treatment
of moniliasis, or mycotic colitis.
• Fibrauretnire Suppositories: for
treatment of vulvar moniliasis vaginosis;
• Omeprazole Sodium Injection: for
treatment of digestive ulcers, gastrinoma, stress ulcers and Reflux Esophagitis.
This drug can prevent stress states and upper postoperative digestive tract
bleeding and aspiration pneumonitis by general anesthetics;
• Ozagrel Sodium
Injection: for treatment of acute cerebral infarction and accompanied
impediments;
• Citicoline Sodium Injection: for treatment of acute brain
injury and postoperative consciousness impediment;
• Tiopronin Injection:
for improving liver function from liver inflammation, fatty liver, alcoholic
hepatitis, medication injury, and heavy metal detox. This drug can reduce toxic
and side effects of chemotherapy and has a notable curative effect on cataracts
and vitreous opacities in early stages;
• Carbazochrome Sodium Sulfonate
Injection: for treatment of the urinary system, upper digestive tract,
respiratory system and obstetric hemorrhage;
• Diltiazem Hydrochloride
Injection: for treatment of paroxysmal supraventricular tachycardia and unstable
angina pectoris. This drug can also be used for high-blood pressure during an
operation or for severe hypertension.
